What type of study is this?

This is a Quantitative Study study.

September 12, 2025JEADV Clinical PracticeOpen Access

Treating to Target in Hidradenitis Suppurativa: Canadian Perspectives

View Full Paper

Ask AI

Bookmark

Authors

Proposes a treat-to-target strategy for hidradenitis suppurativa, highlighting necessary targets and outcomes.

The proposed treat-to-target approach aims for HiSCR 25 at Week 12 and HiSCR 50 by Weeks 24–48 for hidradenitis suppurativa.
Recent guidelines inform treatment options, with a focus on achieving specific clinical response metrics and improving quality of life.
Key interventions include a combination of medical and surgical therapies to manage severity and prevent complications.
The holistic plan emphasizes patient monitoring and adjustments based on treatment response to improve overall outcomes.

Gulliver et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark